ScreenerHero

IBOImpact BioMedical Inc. Common Stock

AMEX · US · Healthcare · Biotechnology · impactbiomedinc.com
0.4800USD+10.80%Mkt Cap: 51.75M $P/E: 0.55

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer heal…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap51.75M $
Enterprise Value54.99M $
Revenue (TTM)35.00K $
Gross Profit-392.00K $
Net Income (TTM)-11.84M $
Revenue/Share0.0000 USD
Last Price0.4800 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.55
P/E (Forward)—
PEG—
EV/EBITDA-13.91
EV/Revenue1571.15
P/S1478.69
P/B4.80
EPS (TTM)0.88
EPS (Forward)—
52W Range
0.370024% of range0.8300
52W High0.8300 USD
52W Low0.3700 USD
Profitability
Gross Margin-1225.00%
Oper. Margin-23400.00%
EBITDA Margin0.00%
Profit Margin-36993.75%
ROE-93.89%
ROA-68.01%
Growth
Revenue Growth-57.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.89M $
CapEx (TTM)—
FCF Margin2905.36%
FCF Yield1.96%
Net Debt-10.00K $
Net Debt/EBITDA0.00
Balance Sheet
Debt/Equity9.49
Current Ratio0.16
Quick Ratio0.01
Book Value/Sh0.1000 USD
Cash/Share0.0000 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.107.82M
Float11.49M
Insiders89.02%
Institutions3.56%
Short Interest
Short Ratio13.4d
Short % Float4.72%
Short % Out.0.51%
Shares Short554.91K
Short (prev mo.)556.49K
Technical
SMA 500.4680 (+2.6%)
SMA 2000.5167 (-7.1%)
Beta—
S&P 52W Chg19.18%
Avg Vol (30d)28.87K
Avg Vol (10d)34.02K
Technical Indicators
RSI (14)57.0
MACD-0.0003
MACD Signal-0.0057
MACD Hist.+0.0054
BB Upper0.4762 USD
BB Middle0.4432 USD
BB Lower0.4103 USD
BB Width14.85%
ATR (14)0.0293 USD
Vol Ratio (20d)0.76x